Dno ASA (0MHP)
London Stock Exchange · UK · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 23.91 |
|---|---|
| 52-week range | 12.95 – 23.91 |
| Return, 1 month / 3 months | +24.3% / +39.3% |
| Return, 1 year / 3 years | +86.8% / +177.1% |
| Trend | Uptrend |
| RSI (14) | 83 |
| Volatility (1 year) | 36.4% |
| Worst drawdown (1 year) | -26.8% |
| Average daily value traded | 3.77M NOK |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
DNO ASA is a Norwegian oil and gas company based in Oslo. It explores for and produces crude oil and natural gas, with operations centred on the Kurdistan region of Iraq and the North Sea, and it also holds interests in other producing fields. Its customers are the buyers of its crude oil and gas output, and it manages exploration, development and production activities through subsidiaries and partners in the regions where it operates.
Dno ASA trades under the code 0MHP on the London Stock Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dno ASA (0MHP) trades on the London Stock Exchange in UK. It last closed at NOK 23.91 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 493 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 86.8% and over the last three months it rose 39.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 31.8% | ||
| From 52-week high | 0.0% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 39.3% | ||
| 6-month return | 24.8% | ||
| 12-month return, skipping the last month | 50.2% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.8% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.77M NOK | ||
| Zero-volume days | 8.3% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | +24.3% |
| 3 months | +39.3% |
| 6 months | +24.8% |
| 1 year | +86.8% |
| 3 years | +177.1% |
| 5 years | +171.0% |
Signals
| 50-day / 200-day average | 19.65 / 18.14 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Nov 2025 | NOK 0.3750 |
| 28 Aug 2025 | NOK 0.3750 |
| 22 May 2025 | NOK 0.3125 |
| 13 Feb 2025 | NOK 0.3125 |
| 14 Nov 2024 | NOK 0.3125 |
| 22 Aug 2024 | NOK 0.3125 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.